Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Eden Research stock price, quote, forecast and news

EDEN.L
GB0001646941
A0Q7CY

Price

0.04
Today +/-
+0
Today %
+0 %
P

Eden Research stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Eden Research stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Eden Research stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Eden Research stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Eden Research's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Eden Research Stock Price History

DateEden Research Price
9/13/20240.04 undefined
9/12/20240.04 undefined
9/11/20240.04 undefined
9/10/20240.04 undefined
9/9/20240.04 undefined
9/6/20240.04 undefined
9/5/20240.04 undefined
9/4/20240.04 undefined
9/3/20240.04 undefined
9/2/20240.04 undefined
8/30/20240.04 undefined
8/29/20240.04 undefined
8/28/20240.04 undefined
8/27/20240.04 undefined
8/23/20240.04 undefined
8/22/20240.04 undefined
8/21/20240.04 undefined
8/20/20240.04 undefined
8/19/20240.04 undefined

Eden Research Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Eden Research, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Eden Research from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Eden Research’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Eden Research. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Eden Research’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Eden Research’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Eden Research’s growth potential.

Eden Research Revenue, EBIT and net profit per share

DateEden Research RevenueEden Research EBITEden Research Net Income
2025e6.84 M undefined-3.23 M undefined-4.11 M undefined
2024e5.05 M undefined-1.72 M undefined-1.45 M undefined
20233.19 M undefined-1.87 M undefined-6.49 M undefined
20221.83 M undefined-2.57 M undefined-2.24 M undefined
20211.23 M undefined-3.21 M undefined-2.79 M undefined
20201.37 M undefined-2.24 M undefined-2.27 M undefined
20191.83 M undefined-1.36 M undefined-1.14 M undefined
20182.77 M undefined-497,040 undefined-334,950 undefined
20171.88 M undefined-1.35 M undefined-639,090 undefined
2016391,960 undefined-1.89 M undefined-1.83 M undefined
2015883,310 undefined-1.14 M undefined-1.16 M undefined
201499,860 undefined-1.75 M undefined-2.97 M undefined
201380,000 undefined-1.58 M undefined-1.59 M undefined
201240,000 undefined-1.6 M undefined-2.26 M undefined
201190,000 undefined-1.83 M undefined-3.28 M undefined
2010170,000 undefined-2.26 M undefined-3.25 M undefined
2009190,000 undefined-1.64 M undefined-1.73 M undefined
200880,000 undefined-2.03 M undefined-2.1 M undefined
2007360,000 undefined-2.5 M undefined-2.46 M undefined
2006100,000 undefined-3.52 M undefined-3.68 M undefined
20050 undefined-2.47 M undefined-2.58 M undefined
200430,000 undefined-2.3 M undefined-2.3 M undefined

Eden Research Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (k)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024e2025e
000000000000000121111356
----------------100.00-50.00---200.0066.6720.00
---------------100.0050.00----33.33--
0000000000000001,0001,00000001,00000
-1-1-2-2-3-2-2-1-2-1-1-1-1-1-1-10-1-2-3-2-1-1-3
----------------100.00--100.00-200.00-300.00-200.00-33.33-20.00-50.00
-1-1-2-2-3-2-2-1-3-3-2-1-2-1-100-1-2-2-2-6-1-4
--100.00-50.00-33.33--50.00200.00--33.33-50.00100.00-50.00----100.00--200.00-83.33300.00
17.5323.8943.8944.7145.794854.4457.0662.4689.64107.31121.97125.95155.93178.72196.01207.44208.24344.63380.34380.55420.9200
------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Eden Research Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Eden Research is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (k)OTHER CURRENT LIAB. (k)CURRENT ASSETS (M)TANGIBLE ASSETS (k)LONG-T. INVEST. (k)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (k)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (k)SHORT-TERM REC. (M)LONG-T. LIAB. (k)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
2002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
                                           
0.010.290.05000.660.010.080.010.390.340.310.410.151.533.682.480.57.293.831.997.41
000.0500.030000.060.10.050.120.030.150.090.730.521.350.910.690.321.79
0.020.210.060.070.130.11000.0200.010.010.030.020.140.190.330.40.581.070.570.82
000000000000000206.8114.6668.42224.42521.35625.46964.55
0000000000000014.9442.9576.06155.66187.0521.9289.75162.41
0.030.50.160.070.160.770.010.080.090.490.40.440.480.311.774.853.412.479.196.143.611.14
00101010010000000000061.75582.68605.07531.6442.53
0000000000000823.58811.17804.88790.74749.74419.87361.69330.24297.2
00000000000000000001.070.570
1.5810.619.68.538.018.159.28.768.27.086.536.095.925.545.214.935.025.586.737.928.454.71
1.030.510.330000000000000000000
0000000000000000000000
2.6111.129.948.548.028.159.218.768.27.086.536.095.926.376.025.745.816.397.739.969.885.45
2.6411.6210.18.618.188.929.228.848.297.576.936.536.46.687.810.599.228.8616.9216.113.4816.59
                                           
0.220.430.450.450.470.530.560.620.670.991.111.231.541.591.852.072.072.073.83.83.815.33
8.558.879.629.6210.1512.3913.1214.1514.7520.1222.3523.2826.0126.8629.1431.2831.2931.2939.3139.3139.316.41
-6.741.21-1.09-3.66-5.65-6.76-8.65-10.01-12.82-15.07-17.24-18.83-21.61-22.52-24.22-24.83-25.08-26.03-28.2-30.31-32.41.77
000000000000000000011.1810.940
0000000000000000000000
2.0310.518.986.414.976.165.034.762.66.046.225.685.945.936.768.518.287.3414.9123.9821.6613.52
0.220.340.10.380.480.830.750.910.810.880.130.290.290.330.121.560.50.870.791.151.154.74
2020605080100240701400300150144.24399.94803.63379.83328.51309.78293.2485.91568.71697.18
0.350.750.971.7700.010.050.030.6500.290.010.020.030.040.070.050.170.370.080.090.2
0.01000.012.661.832.272.052.950.6500.40000000000
0000000000000000022.8184.3599.92139.55142.85
0.61.111.132.213.222.773.313.064.551.530.720.850.460.750.9720.881.371.541.811.955.78
0000000000000000046.69330.9298.43215.7886.92
0000000000000000000000
0000001.061.061.13000000.070.070.070.10.130.0900
0000001.061.061.13000000.070.070.070.150.460.390.220.09
0.61.111.132.213.222.774.374.125.681.530.720.850.460.751.032.070.941.5222.22.175.87
2.6311.6210.118.628.198.939.48.888.287.576.946.536.46.687.810.599.228.8516.926.1823.8319.39
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Eden Research provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Eden Research's financial health and stability.

Assets

Eden Research's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Eden Research must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Eden Research after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Eden Research's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (k)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (k)PAID INTEREST (k)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
200220032004200520062007200820092010201120122013201420152016201720182019202020212022
-1-1-2-2-3-2-2-1-3-3-2-1-2-1-100-1-2-2-2
001,0001,0001,00000001,0001,0001,0001,0001,0001,0001,00000000
000000000000000000000
000000000-100000000000
00001,0001,000001,0001,000001,00000000000
0000000001,00000000000000
000000000000000000000
-10-1000-10-1-2-1-100000-1-1-10
000000000000000000-1-1-1
000000000000000000-1-1-1
000000000000000000000
000000000000000000000
000000001210000000000
1000020001010022001000
100011101311102200900
---------------------
000000000000000000000
0000000000000012-1-16-3-1
-1.48-0.1-1.22-0.75-1.26-0.82-1.85-0.63-1.85-2.94-1.73-1.44-1.4-0.24-1.15-0.24-1.21-1.93-2.92-3.34-1.74
000000000000000000000

Eden Research stock margins

The Eden Research margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Eden Research. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Eden Research.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Eden Research's sales revenue. A higher gross margin percentage indicates that the Eden Research retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Eden Research's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Eden Research's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Eden Research's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Eden Research. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Eden Research's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Eden Research Margin History

Eden Research Gross marginEden Research Profit marginEden Research EBIT marginEden Research Profit margin
2025e55.31 %-47.24 %-60 %
2024e55.31 %-34 %-28.8 %
202355.31 %-58.48 %-203.45 %
202245.43 %-140.49 %-122.44 %
202145.68 %-261.14 %-227.01 %
202046.2 %-163.31 %-165.84 %
201948.42 %-74.37 %-62.71 %
201855.41 %-17.92 %-12.07 %
201755.71 %-71.99 %-34.05 %
201692.71 %-481.26 %-467.16 %
201588.82 %-128.9 %-131 %
201455.31 %-1,748.08 %-2,973.63 %
201355.31 %-1,975 %-1,987.5 %
201255.31 %-4,000 %-5,650 %
201155.31 %-2,033.33 %-3,644.44 %
2010100 %-1,329.41 %-1,911.76 %
2009100 %-863.16 %-910.53 %
2008100 %-2,537.5 %-2,625 %
2007100 %-694.44 %-683.33 %
2006100 %-3,520 %-3,680 %
200555.31 %0 %0 %
2004100 %-7,666.67 %-7,666.67 %

Eden Research Stock Sales Revenue, EBIT, Earnings per Share

The Eden Research earnings per share therefore indicates how much revenue Eden Research has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Eden Research earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Eden Research's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Eden Research’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Eden Research's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Eden Research Revenue, EBIT and net profit per share

DateEden Research Sales per ShareEden Research EBIT per shareEden Research Earnings per Share
2025e0.01 undefined0 undefined-0.01 undefined
2024e0.01 undefined0 undefined-0 undefined
20230.01 undefined-0 undefined-0.02 undefined
20220 undefined-0.01 undefined-0.01 undefined
20210 undefined-0.01 undefined-0.01 undefined
20200 undefined-0.01 undefined-0.01 undefined
20190.01 undefined-0.01 undefined-0.01 undefined
20180.01 undefined-0 undefined-0 undefined
20170.01 undefined-0.01 undefined-0 undefined
20160 undefined-0.01 undefined-0.01 undefined
20150.01 undefined-0.01 undefined-0.01 undefined
20140 undefined-0.01 undefined-0.02 undefined
20130 undefined-0.01 undefined-0.01 undefined
20120 undefined-0.01 undefined-0.02 undefined
20110 undefined-0.02 undefined-0.04 undefined
20100 undefined-0.04 undefined-0.05 undefined
20090 undefined-0.03 undefined-0.03 undefined
20080 undefined-0.04 undefined-0.04 undefined
20070.01 undefined-0.05 undefined-0.05 undefined
20060 undefined-0.08 undefined-0.08 undefined
20050 undefined-0.06 undefined-0.06 undefined
20040 undefined-0.05 undefined-0.05 undefined

Eden Research business model

Eden Research PLC is a British company specializing in the development and marketing of natural products for crop protection and the food industry. The company was founded in 1996 and is headquartered in Cirencester, Gloucestershire. Answer: Eden Research PLC is a British company that specializes in the development and marketing of natural products for crop protection and the food industry. Eden Research is one of the most popular companies on Eulerpool.com.

Eden Research SWOT Analysis

Strengths

Eden Research PLC has several strengths that contribute to its success:

  • Strong Intellectual Property portfolio, providing a competitive advantage in the industry.
  • Technological expertise in developing and commercializing sustainable crop protection and animal care products.
  • Established relationships with distributors and partners globally, facilitating market expansion.
  • Continuous investment in research and development, enabling innovation and product improvement.

Despite its strengths, Eden Research PLC also faces some weaknesses:

  • Reliance on a limited number of key customers, increasing the vulnerability to potential revenue fluctuations.
  • High dependency on government regulations and approvals for product commercialization, which can cause delays and uncertainty.
  • Relatively small size compared to some competitors, limiting resources and market reach.

There are several opportunities that Eden Research PLC can capitalize on:

  • Increasing demand for sustainable and environmentally friendly solutions in the agriculture and animal care industries.
  • Growing global population and the need for improved crop yields and quality.
  • Potential for expansion into new geographic markets to diversify revenue streams.
  • Collaboration opportunities with industry stakeholders to develop and promote innovative solutions.

Eden Research PLC should be aware of the following threats to its business:

  • Intense competition from larger and more established companies within the agricultural and animal care sectors.
  • Regulatory challenges and changing legislation affecting the use and approval of crop protection products.
  • Economic downturns or market fluctuations impacting customer demand and purchasing power.
  • Risks associated with potential environmental and health concerns related to the use of certain chemical compounds.

Weaknesses

Despite its strengths, Eden Research PLC also faces some weaknesses:

  • Reliance on a limited number of key customers, increasing the vulnerability to potential revenue fluctuations.
  • High dependency on government regulations and approvals for product commercialization, which can cause delays and uncertainty.
  • Relatively small size compared to some competitors, limiting resources and market reach.

There are several opportunities that Eden Research PLC can capitalize on:

  • Increasing demand for sustainable and environmentally friendly solutions in the agriculture and animal care industries.
  • Growing global population and the need for improved crop yields and quality.
  • Potential for expansion into new geographic markets to diversify revenue streams.
  • Collaboration opportunities with industry stakeholders to develop and promote innovative solutions.

Eden Research PLC should be aware of the following threats to its business:

  • Intense competition from larger and more established companies within the agricultural and animal care sectors.
  • Regulatory challenges and changing legislation affecting the use and approval of crop protection products.
  • Economic downturns or market fluctuations impacting customer demand and purchasing power.
  • Risks associated with potential environmental and health concerns related to the use of certain chemical compounds.

Opportunities

There are several opportunities that Eden Research PLC can capitalize on:

  • Increasing demand for sustainable and environmentally friendly solutions in the agriculture and animal care industries.
  • Growing global population and the need for improved crop yields and quality.
  • Potential for expansion into new geographic markets to diversify revenue streams.
  • Collaboration opportunities with industry stakeholders to develop and promote innovative solutions.

Eden Research PLC should be aware of the following threats to its business:

  • Intense competition from larger and more established companies within the agricultural and animal care sectors.
  • Regulatory challenges and changing legislation affecting the use and approval of crop protection products.
  • Economic downturns or market fluctuations impacting customer demand and purchasing power.
  • Risks associated with potential environmental and health concerns related to the use of certain chemical compounds.

Threats

Eden Research PLC should be aware of the following threats to its business:

  • Intense competition from larger and more established companies within the agricultural and animal care sectors.
  • Regulatory challenges and changing legislation affecting the use and approval of crop protection products.
  • Economic downturns or market fluctuations impacting customer demand and purchasing power.
  • Risks associated with potential environmental and health concerns related to the use of certain chemical compounds.

Eden Research Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Eden Research historical P/E ratio, EBIT, and P/S ratio.

Eden Research shares outstanding

The number of shares was Eden Research in 2023 — This indicates how many shares 420.921 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Eden Research earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Eden Research's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Eden Research’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Eden Research's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Unfortunately, there are currently no price targets and forecasts available for Eden Research.

Eden Research list of shareholders

%
Name
Stocks
Change
Date
7.79053 % Octopus Investments Limited41,551,04741,551,04710/6/2023
7.05252 % SIPCAM SpA37,614,83003/21/2023
5.95058 % Hargreaves Lansdown Asset Management Limited31,737,5961,115,5603/21/2023
5.22083 % Gresham House Asset Management Limited27,845,44503/21/2023
4.32676 % Unicorn Asset Management Ltd.23,076,92323,076,92310/6/2023
4.23434 % Canaccord Genuity Wealth Management22,584,00003/21/2023
3.71982 % J. M. Finn & Co.19,839,762-77,6003/21/2023
3.39692 % Unadkat (Atul)18,117,567542,1813/21/2023
3.13940 % Amati Global Investors Limited16,744,0705,561,41810/6/2023
2.87389 % BGF Investment Management Limited15,328,000-4,905,0001/12/2024
1
2
3
4
5
...
7

Eden Research Executives and Management Board

Mr. Sean Smith
Eden Research Chief Executive Officer, Executive Director (since 2014)
Compensation 360,376
Mr. Alex Abrey
Eden Research Chief Financial Officer, Company Secretary, Executive Director (since 2007)
Compensation 270,638
Mr. Lykele van der Broek
Eden Research Non-Executive Independent Chairman of the Board
Compensation 45,000
Mr. Robin Cridland54
Eden Research Non-Executive Independent Director
Compensation 40,000
1

Eden Research Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Hargreaves Lansdown Stock
Hargreaves Lansdown
SupplierCustomer-0,730,760,870,880,54
Corteva Stock
Corteva
SupplierCustomer--0,04-0,31-0,85-0,830,02
Elanco Animal Health Stock
Elanco Animal Health
SupplierCustomer-0,470,710,750,880,49
Eastman Chemical Stock
Eastman Chemical
SupplierCustomer-0,250,700,750,190,33
Gresham House Stock
Gresham House
SupplierCustomer-0,55-0,35-0,350,05-
Sumitomo Stock
Sumitomo
SupplierCustomer-0,620,15-0,77-0,84-0,26
Canaccord Genuity Group Stock
Canaccord Genuity Group
SupplierCustomer-0,690,730,870,500,16
Ackermans & van Haaren Stock
Ackermans & van Haaren
SupplierCustomer-0,340,11-0,02-0,77-0,29
1

Most common questions regarding Eden Research

What values and corporate philosophy does Eden Research represent?

Eden Research PLC represents values of innovation, sustainability, and excellence in the field of crop protection. With a focus on natural and environmentally friendly solutions, the company is committed to delivering effective and safe products for pest and disease control in agriculture. Eden Research PLC aims to provide farmers with sustainable alternatives to conventional chemicals, promoting healthier farming practices and reducing environmental impact. By emphasizing research and development, the company strives to stay at the forefront of technological advancements in crop protection. As a result, Eden Research PLC is dedicated to improving agricultural practices and supporting the global food supply chain.

In which countries and regions is Eden Research primarily present?

Eden Research PLC is primarily present in various countries and regions. The company has a global presence with a focus on Europe, North America, and Asia Pacific. It has established a strong foothold in countries such as the United Kingdom, France, Germany, Italy, Spain, and the Netherlands within Europe. In North America, Eden Research PLC operates in the United States, while in the Asia Pacific region, it has a presence in China and Australia. With its extensive international presence, Eden Research PLC is well-positioned to serve a wide range of customers and expand its global footprint in the agricultural and chemical sectors.

What significant milestones has the company Eden Research achieved?

Eden Research PLC has achieved several significant milestones. The company successfully developed and commercialized a proprietary technology, known as Sustaine®, which is a natural and sustainable alternative to conventional crop protection products. Eden Research PLC also received regulatory approval for the first sales of its products in Europe, South America, and Africa. The company has entered into strategic partnerships with leading agricultural companies, expanding its global reach and market presence. Furthermore, Eden Research PLC has received prestigious industry recognitions for its innovative products and eco-friendly solutions, positioning itself as a key player in the agrochemical industry.

What is the history and background of the company Eden Research?

Eden Research PLC, a renowned company in the stock market, has a rich history and an impressive background. Established in [year], Eden Research PLC has emerged as a prominent player in the industry. The company focuses on developing sustainable and innovative solutions for crop protection and plant health. With a dedicated team of experts, Eden Research PLC has successfully commercialized its innovative technology, delivering effective and environmentally friendly solutions for the agricultural sector. By leveraging their expertise and cutting-edge research, Eden Research PLC continues to contribute towards global food security and sustainable agriculture. The company's commitment to excellence and innovation sets it apart in the market, making it a promising investment opportunity.

Who are the main competitors of Eden Research in the market?

The main competitors of Eden Research PLC in the market are companies like Syngenta, Bayer, DowDupont, and BASF.

In which industries is Eden Research primarily active?

Eden Research PLC is primarily active in the agricultural, horticultural, and crop protection industries.

What is the business model of Eden Research?

Eden Research PLC operates on an innovative business model focused on developing and commercializing plant protection products. As a leading company in sustainable crop protection solutions, Eden Research PLC leverages its expertise in natural chemistry to create effective and environmentally friendly alternatives to conventional pesticides. By utilizing its proprietary technologies, such as its encapsulation and terpene-based formulations, Eden Research PLC offers a range of biocontrol products that minimize the impact on ecosystems while maximizing crop yields. Through strategic partnerships and collaborations, the company aims to address the growing demand for sustainable agriculture, contributing to the long-term prosperity of farmers and the agriculture industry.

What is the P/E ratio of Eden Research 2024?

The Eden Research P/E ratio is -11.87.

What is the P/S ratio of Eden Research 2024?

The Eden Research P/S ratio is 3.42.

What is the AlleAktien quality score of Eden Research?

The AlleAktien quality score for Eden Research is 4/10.

What is the revenue of Eden Research 2024?

The expected Eden Research revenue is 5.05 M GBP.

How high is the profit of Eden Research 2024?

The expected Eden Research profit is -1.45 M GBP.

What is the business model of Eden Research

Eden Research PLC is a company that specializes in the development, sale, and marketing of biological crop protection products. The company was founded in 1996 and is headquartered in the United Kingdom. It is listed on the London Stock Exchange (AIM: EDEN). The company's business model is based on the marketing of crop protection products under the brand names "3AEY," "Mevalone," and "Cedroz." These products are based on a proprietary technology platform and are typically sold to farmers, plantation operators, and other agricultural companies. Eden Research PLC's products are biodegradable and environmentally friendly, leading to a growing demand for sustainable crop protection products in the agricultural industry. This has made the company a market leader in this field in recent years. In addition to manufacturing and selling crop protection products, Eden Research PLC also offers agricultural consulting services. The company supports its customers in transitioning to organic farming methods and complying with environmental regulations. Eden Research PLC is also involved in research and development. The company continuously works on improving its products and developing new products based on its technology platform. It has filed several patents for its technology and continually invests in research and development. The company has also formed several strategic partnerships with major agricultural companies globally to enhance the distribution of its products and expand its customer base. Additionally, it has entered into distribution agreements with various distributors and dealers in different countries to expand its presence worldwide. Overall, Eden Research PLC's business model is focused on sustainable and environmentally friendly agriculture. The company has a proprietary technology platform that allows it to manufacture and market biological crop protection products. It also provides agricultural consulting services and continuously invests in research and development. Through its strategic partnerships and distribution agreements, it has expanded its global presence and established itself as a market leader in the field of biological crop protection products.

What is the Eden Research dividend?

Eden Research pays a dividend of 0 GBP distributed over payouts per year.

How often does Eden Research pay dividends?

The dividend cannot currently be calculated for Eden Research or the company does not pay out a dividend.

What is the Eden Research ISIN?

The ISIN of Eden Research is GB0001646941.

What is the Eden Research WKN?

The WKN of Eden Research is A0Q7CY.

What is the Eden Research ticker?

The ticker of Eden Research is EDEN.L.

How much dividend does Eden Research pay?

Over the past 12 months, Eden Research paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Eden Research is expected to pay a dividend of 0 GBP.

What is the dividend yield of Eden Research?

The current dividend yield of Eden Research is .

When does Eden Research pay dividends?

Eden Research pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Eden Research?

Eden Research paid dividends every year for the past 0 years.

What is the dividend of Eden Research?

For the upcoming 12 months, dividends amounting to 0 GBP are expected. This corresponds to a dividend yield of 0 %.

In which sector is Eden Research located?

Eden Research is assigned to the 'Commodities' sector.

Wann musste ich die Aktien von Eden Research kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Eden Research from 9/16/2024 amounting to 0 GBP, you needed to have the stock in your portfolio before the ex-date on 9/16/2024.

When did Eden Research pay the last dividend?

The last dividend was paid out on 9/16/2024.

What was the dividend of Eden Research in the year 2023?

In the year 2023, Eden Research distributed 0 GBP as dividends.

In which currency does Eden Research pay out the dividend?

The dividends of Eden Research are distributed in GBP.

All fundamentals about Eden Research

Our stock analysis for Eden Research Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Eden Research Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.